高測股份(688556.SH):減持期滿 濰坊善美以集中競價累計減持2%的股份
格隆匯3月24日丨高測股份(688556.SH)公佈,公司於2022年3月24日收到濰坊善美出具的《股份減持結果的吿知函》。截至2022年3月24日,濰坊善美本次減持計劃時間屆滿,在減持計劃時間區間內,其通過集中競價交易方式累計減持公司股份323.7028萬股,佔公司總股本的2.0000%。同時,自前次披露減持進展公吿後,濰坊善美自2022年2月28日至2022年3月24日期間,其通過集中競價交易方式累計減持公司股份161.8514萬股,佔公司總股本的1.0000%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.